KLP Kapitalforvaltning
DNA icon

KLP Kapitalforvaltning’s Ginkgo Bioworks DNA Stock Holding History

KLP Kapitalforvaltning’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$92.2K Hold
7,183
– – ﹤0.01% 2092
2026
Q2 		$71.2K Hold
7,183
– – ﹤0.01% 2115
2026
Q1 		$44K Hold
7,183
– – ﹤0.01% 2142
2025
Q4 		$59.7K Buy
7,183
+2,500
+53% +$26.9K ﹤0.01% 2139
2025
Q3 		$68.3K Hold
4,683
– – ﹤0.01% 2122
2025
Q2 		$52.7K Hold
4,683
– – ﹤0.01% 2156
2025
Q1 		$26.7K Hold
4,683
– – ﹤0.01% 2239
2024
Q4 		$46K Buy
+4,683
New +$40.1K ﹤0.01% 2251

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
J.M. Forbes & Co
J.M. Forbes & Co Boston, Massachusetts $1.33B AUM 21.14% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Exchange Traded Concepts
Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.11B AUM 20.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

KLP Kapitalforvaltning's DNA Position: Q3 2026 in Review

KLP Kapitalforvaltning held its Ginkgo Bioworks (DNA) position steady in Q3 2026 at 7,183 shares worth $92.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2092.

KLP Kapitalforvaltning first reported a position in DNA in Q4 2024 and has held it in 8 quarters since. 76 funds tracked by Wall St. Rank hold DNA as of Q3 2026.

  • KLP Kapitalforvaltning held 7,183 shares of Ginkgo Bioworks worth $92.2K as of Q3 2026.
  • KLP Kapitalforvaltning left its Ginkgo Bioworks share count unchanged in Q3 2026.
  • Ginkgo Bioworks made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q3 2026, its #2092 holding.
  • KLP Kapitalforvaltning first reported a position in Ginkgo Bioworks in Q4 2024 and has held it in 8 quarters since.
  • 76 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q3 2026, filed 10 Nov 2026.